Evidence map›Paper›PMID 38478578›Full record

ArticleBrain : a journal of neurology2024

Digenic Leigh syndrome on the background of the m.11778G>A Leber hereditary optic neuropathy variant.

Beryll Blickhäuser, Sarah L Stenton, Christiane M Neuhofer, Elisa Floride, Victoria Nesbitt, Carl Fratter, Johannes Koch, Birgit Kauffmann, Claudia Catarino, Lea Dewi Schlieben and 14 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Review
  5. Article
  6. Article
  7. RNA Sequencing Resolves Cryptic Pathogenic Variants in Mitochondrial Disease.Annals of clinical and translational neurology · 2026
    Article
  8. Article
  9. Identification of co-segregatingFrontiers in medicine · 2025
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 16 institutions in 8 countries.

Beryll BlickhäuserInstitute of Neurogenomics, Computational Health Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Sarah L StentonDivision of Genetics and Genomics, Boston Children's Hospital, Boston, MA 02115, USA.
Christiane M NeuhoferInstitute of Neurogenomics, Computational Health Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Elisa FlorideInstitute for Human Genetics, Paracelsus Medical University (PMU), 5020 Salzburg, Austria.
Victoria NesbittNHS Highly Specialised Services for Rare Mitochondrial Disorders, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7HE, UK.
Carl FratterNHS Highly Specialised Services for Rare Mitochondrial Disorders, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7HE, UK.
Johannes KochUniversity Children's Hospital, Department of Neuropediatrics, Paracelsus Medical University (PMU), 5020 Salzburg, Austria.
Birgit KauffmannKlinikum Bremen Mitte, Department of Pediatrics, Neuropediatrics, 28205 Bremen, Germany.
Claudia CatarinoFriedrich-Baur-Institute, Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.
Lea Dewi SchliebenInstitute of Neurogenomics, Computational Health Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Robert KopajtichInstitute of Neurogenomics, Computational Health Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Valerio CarelliIRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, 40139 Bologna, Italy.
Alfredo A SadunDoheny Eye Institute, Pasadena, CA 91105, USA.
Robert McFarlandWellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
Fang FangDepartment of Pediatric Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, 100005 Beijing, China.
Chiara La MorgiaIRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, 40139 Bologna, Italy.
Stéphanie PaquayDepartment of Neuropediatrics, University Hospital St Luc, UCLouvain, 1200 Bruxelles, Belgium.
Marie Cécile NassogneDepartment of Neuropediatrics, University Hospital St Luc, UCLouvain, 1200 Bruxelles, Belgium.
Daniele GhezziUnit of Medical Genetics and Neurogenetics, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Neurologico Carlo Besta, 20133 Milan, Italy.ORCID 0000-0002-6564-3766
Costanza LampertiUnit of Medical Genetics and Neurogenetics, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Neurologico Carlo Besta, 20133 Milan, Italy.
Saskia WortmannUniversity Children's Hospital, Department of Neuropediatrics, Paracelsus Medical University (PMU), 5020 Salzburg, Austria.
Jo PoultonNuffield Department of Women's and Reproductive Health University of Oxford, The Women's Centre, Oxford, OX3 9DU, UK.
Thomas KlopstockFriedrich-Baur-Institute, Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.
Holger ProkischInstitute of Neurogenomics, Computational Health Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.ORCID 0000-0003-2379-6286
Helmholtz Zentrum München · DECliniques Universitaires Saint-Luc · BEIstituto delle Scienze Neurologiche di Bologna · ITOxford University Hospitals NHS Trust · GBRadboud University Nijmegen · NLBroad Institute · USCapital Medical University · CNGerman Center for Neurodegenerative Diseases · DEIstituti di Ricovero e Cura a Carattere Scientifico · ITKlinikum Bremen-Mitte · DELudwig-Maximilians-Universität München · DENewcastle upon Tyne Hospitals NHS Foundation Trust · GBParacelsus Medical University · ATUniversity of California, Los Angeles · USUniversity of Milan · ITUniversity of Oxford · GB

Funding

Austrian Science FundsEarly Career Award from the Thrasher Research FundGerman Federal Ministry of Education and ResearchManton Center for Orphan Disease Research, Boston Children's HospitalUK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children
6 · The paper itself

Abstract

Leigh syndrome spectrum (LSS) is a primary mitochondrial disorder defined neuropathologically by a subacute necrotizing encephalomyelopathy and characterized by bilateral basal ganglia and/or brainstem lesions. LSS is associated with variants in several mitochondrial DNA genes and more than 100 nuclear genes, most often related to mitochondrial complex I (CI) dysfunction. Rarely, LSS has been reported in association with primary Leber hereditary optic neuropathy (LHON) variants of the mitochondrial DNA, coding for CI subunits (m.3460G>A in MT-ND1, m.11778G>A in MT-ND4 and m.14484T>C in MT-ND6). The underlying mechanism by which these variants manifest as LSS, a severe neurodegenerative disease, as opposed to the LHON phenotype of isolated optic neuropathy, remains an open question. Here, we analyse the exome sequencing of six probands with LSS carrying primary LHON variants, and report digenic co-occurrence of the m.11778G > A variant with damaging heterozygous variants in nuclear disease genes encoding CI subunits as a plausible explanation. Our findings suggest a digenic mechanism of disease for m.11778G>A-associated LSS, consistent with recent reports of digenic disease in individuals manifesting with LSS due to biallelic variants in the recessive LHON-associated disease gene DNAJC30 in combination with heterozygous variants in CI subunits.

Indexed as

Leigh DiseaseOptic Atrophy, Hereditary, LeberAdolescentAdultChildChild, PreschoolDNA, MitochondrialElectron Transport Complex IExome SequencingFemaleHumansMaleMutationNADH DehydrogenaseYoung AdultDNA, MitochondrialElectron Transport Complex IMT-ND6 protein, humanNADH DehydrogenaseNADH dehydrogenase subunit 1, humanNADH dehydrogenase subunit 4digenic inheritanceLeber hereditary optic neuropathy (LHON)Leigh syndrome spectrum (LSS)mitochondrial complex I (CI)

Identifiers

PMID38478578
PMCPMC11146415
OpenAlexW4392739200

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.